Search results: Sage Journals

Restricted accessOtherFirst published March, 2010

Patient Time Requirements for Anticoagulation Therapy with Warfarin

Daniel E. Jonas, Betsy Bryant Shilliday, W. Russell Laundon [...]

Medical Decision Making

Restricted accessResearch articleFirst published October, 2020

Timing of Anticoagulation in Atrial Fibrillation Status Post Cardioembolic Stroke

Ashley Core, Nathan Pinner, Brittany Bethea [...]

Journal of Pharmacy Practice

Open accessResearch articleFirst published December, 2018

Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin

Clara Ting, Katelyn W. Sylvester, James W. Schurr

Clinical and Applied Thrombosis/Hemostasis

Open accessResearch articleFirst published June, 2022

Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial

Jonathan G Best, Liz Arram, Norin Ahmed [...]

International Journal of Stroke

Open accessReview articleFirst published January, 2026

Timing of Chemical Anticoagulant Administration in Spine Trauma and its Impact on VTE,Bleeding,and Mortality: A Systematic Review and Meta-Analysis

Sarthak Mohanty, Hanna von Riegen, Michael Akodu [...]

Global Spine Journal

Restricted accessResearch articleFirst published January, 1996

Validity of International Normalized Ratio in Expressing Prothrombin Times in Anticoagulated and Nonanticoagulated Patients

Rasheed Alshameeri, Eberhard F. Mammen, Christa Paisley [...]

Clinical and Applied Thrombosis/Hemostasis

Free accessResearch articleFirst published July, 2017

Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina

Carlos Tajer, José Ceresetto, Federico Jorge Bottaro [...]

Clinical and Applied Thrombosis/Hemostasis

Restricted accessResearch articleFirst published July, 2020

Anticoagulation Monitoring Under ECMO Support: A Comparative Study Between the Activated Coagulation Time and the Anti-Xa Activity Assay

Clément Delmas, Aemilia Jacquemin, Fanny Vardon-Bounes [...]

Journal of Intensive Care Medicine

Open accessLetterFirst published 2013

Should we Test the Prothrombin Time in Anticoagulated Epistaxis Patients?

Michael B. Soyka, David Holzmann

Therapeutic Advances in Allergy and Rhinology

Restricted accessCase reportFirst published November, 2016

Wide discrepancies in activated clotting times measured by two devices were detected for a patient with lupus anticoagulant in a cardiac surgery

Keika Miyazawa, Yuji Otsuka, Yoshiki Ishiguro

Perfusion

Restricted accessOtherFirst published March, 2010

Patient Time Requirements for Anticoagulation Therapy with Warfarin

Daniel E. Jonas, Betsy Bryant Shilliday, W. Russell Laundon [...]

Medical Decision Making

Restricted accessResearch articleFirst published October, 2020

Timing of Anticoagulation in Atrial Fibrillation Status Post Cardioembolic Stroke

Ashley Core, Nathan Pinner, Brittany Bethea [...]

Journal of Pharmacy Practice

Open accessResearch articleFirst published December, 2018

Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin

Clara Ting, Katelyn W. Sylvester, James W. Schurr

Clinical and Applied Thrombosis/Hemostasis

Open accessResearch articleFirst published June, 2022

Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial

Jonathan G Best, Liz Arram, Norin Ahmed [...]

International Journal of Stroke

Open accessReview articleFirst published January, 2026

Timing of Chemical Anticoagulant Administration in Spine Trauma and its Impact on VTE,Bleeding,and Mortality: A Systematic Review and Meta-Analysis

Sarthak Mohanty, Hanna von Riegen, Michael Akodu [...]

Global Spine Journal

Restricted accessResearch articleFirst published January, 1996

Validity of International Normalized Ratio in Expressing Prothrombin Times in Anticoagulated and Nonanticoagulated Patients

Rasheed Alshameeri, Eberhard F. Mammen, Christa Paisley [...]

Clinical and Applied Thrombosis/Hemostasis

Free accessResearch articleFirst published July, 2017

Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina

Carlos Tajer, José Ceresetto, Federico Jorge Bottaro [...]

Clinical and Applied Thrombosis/Hemostasis

Restricted accessResearch articleFirst published July, 2020

Anticoagulation Monitoring Under ECMO Support: A Comparative Study Between the Activated Coagulation Time and the Anti-Xa Activity Assay

Clément Delmas, Aemilia Jacquemin, Fanny Vardon-Bounes [...]

Journal of Intensive Care Medicine

Open accessLetterFirst published 2013

Should we Test the Prothrombin Time in Anticoagulated Epistaxis Patients?

Michael B. Soyka, David Holzmann

Therapeutic Advances in Allergy and Rhinology

Restricted accessCase reportFirst published November, 2016

Wide discrepancies in activated clotting times measured by two devices were detected for a patient with lupus anticoagulant in a cardiac surgery

Keika Miyazawa, Yuji Otsuka, Yoshiki Ishiguro

Perfusion